|
Market Closed -
Nasdaq
01:30:00 06/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 223.59 USD | +1.69% |
|
-2.23% | +27.05% |
| 02/10 | Biogen's experimental lupus drug shows benefit against skin symptoms | RE |
| 02/10 | Biogen Says Litifilimab Shows Efficacy in New 52-Week Phase 2 Data | MT |
| Market Cap | 3.25TCr 2.9TCr 2.7TCr 2.46TCr 4.63TCr 3,12900Cr 4.66TCr 33TCr 13TCr 1,59700Cr 12TCr 12TCr 5,13300Cr | P/E 2026 * |
35.9x | P/E 2027 * | 19.4x |
|---|---|---|---|---|---|
| Enterprise Value | 3.74TCr 3.34TCr 3.11TCr 2.83TCr 5.33TCr 3,60400Cr 5.37TCr 38TCr 15TCr 1,84000Cr 14TCr 14TCr 5,91300Cr | EV / Sales 2026 * |
3.58x | EV / Sales 2027 * | 3.28x |
| Free-Float |
85.8% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BIIB | Delayed | |
CBOE
| BIIB | Real-time | |
|
Tradegate
| IDP | Real-time | |
|
Börse Stuttgart
| IDP | Delayed | |
|
Xetra
| IDP | Delayed | |
|
Mexican S.E.
| BIIB * | End-of-day quote | |
|
Boerse Muenchen
| IDP | Real-time | |
|
Borsa Italiana
| 1BIIB | End-of-day quote | |
|
Kazakhstan S.E.
| BIIB_KZ | End-of-day quote | |
|
Deutsche Boerse AG
| IDP | Delayed | |
|
Swiss Exchange
| BIIB | Delayed | |
|
Wiener Boerse
| BIIB | End-of-day quote | |
|
Santiago S.E.
| BIIB | End-of-day quote | |
|
Santiago S.E.
| BIIBCL | End-of-day quote | |
|
Swiss Exchange
| BIIB | Delayed |
Last Transcript: Biogen Inc.
| 1 day | +1.69% | ||
| 1 week | -2.23% | ||
| Current month | -1.01% | ||
| 1 month | +5.22% | ||
| 3 months | +7.26% | ||
| 6 months | +29.74% | ||
| Current year | +27.05% |
| 1 week | 218.22 |  | 229.41 |
| 1 month | 208.93 | | 230.49 |
| Current year | 160.36 | | 230.49 |
| 1 year | 138 | | 230.49 |
| 3 years | 110.04 | | 269.43 |
| 5 years | 110.04 | | 319.76 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Daniel Quirk
CTO | Chief Tech/Sci/R&D Officer | - | 28/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
William Hawkins
BRD | Director/Board Member | 72 | 19/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/09/26 | Free | General Counsel | 7,405 | 0.0050% | ||
| 04/08/26 | Sell | Director | -593 | 0.0004% | ||
| 09/06/26 | Free | Director | 1,505 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.69% | -2.23% | +45.14% | -13.93% | 3.25TCr | |
| +0.02% | -3.52% | +35.27% | +111.11% | 1,01900Cr | |
| -1.21% | -6.99% | +34.42% | +60.96% | 62TCr | |
| +1.12% | -0.20% | +15.45% | +80.24% | 46TCr | |
| -3.30% | -6.15% | +57.14% | +34.69% | 36TCr | |
| +0.93% | -3.16% | +21.65% | +43.02% | 33TCr | |
| +0.12% | -2.77% | +10.70% | +32.97% | 27TCr | |
| -0.89% | -6.28% | -7.00% | +8.01% | 24TCr | |
| -0.01% | -3.62% | +37.01% | +52.02% | 22TCr | |
| -0.08% | -4.98% | +27.34% | +93.61% | 18TCr | |
| Average | -0.36% | -3.53% | +27.71% | +50.27% | 37.3TCr | |
| Weighted average by Cap. | -0.37% | -3.54% | +28.82% | +67.88% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.04TCr 931.69Cr 868Cr 789.91Cr 1.49TCr 1,00600Cr 1.5TCr 10TCr 4.08TCr 51TCr 3.92TCr 3.84TCr 1,65000Cr | 1.07TCr 950.78Cr 885.79Cr 806.1Cr 1.52TCr 1,02600Cr 1.53TCr 11TCr 4.16TCr 52TCr 4TCr 3.91TCr 1,68400Cr |
| Net income | 100Cr 89Cr 83Cr 75Cr 141.98Cr 9.6TCr 143.03Cr 1TCr 389.47Cr 4.9TCr 374.19Cr 366.12Cr 16TCr | 185.88Cr 165.82Cr 154.49Cr 140.59Cr 264.76Cr 18TCr 266.72Cr 1.87TCr 726.27Cr 9.14TCr 697.79Cr 682.74Cr 29TCr |
| Net Debt | 493.67Cr 440.4Cr 410.3Cr 373.39Cr 703.16Cr 48TCr 708.37Cr 4.96TCr 1.93TCr 24TCr 1.85TCr 1.81TCr 78TCr | 242Cr 215.89Cr 201.13Cr 183.04Cr 344.69Cr 23TCr 347.25Cr 2.43TCr 945.55Cr 12TCr 908.47Cr 888.87Cr 38TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | $223.59 | +1.69% | 9,36,863 |
| 02/26/02 | $219.88 | -1.32% | 7,80,427 |
| 01/26/01 | $222.82 | -1.35% | 17,55,492 |
| 30/26/30 | $225.88 | -0.52% | 15,53,331 |
| 29/26/29 | $227.07 | -0.71% | 11,61,173 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions
